Company intelligence / Profile preview

Embr Labs

Charlestown, Massachusetts, United Statesembrlabs.com ↗

Ownership: Private
Development stage: Commercial

Overview

Embr Labs’ flagship product, the Embr Wave, has demonstrated effectiveness in providing on-demand relief from hot flashes, sleep disruptions, and stress. Clinical research supports its safety and efficacy as a non-pharmacological solution for temperature discomfort. The company continues to conduct clinical trials to expand its evidence base.

Therapeutic areas: PsychiatryNeurologyWomen's Health
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

Embr Wave

Commercial

Indications: Hot flashes, Night sweats, Sleep disruption, Stress, Dysautonomia

Partnerships

Johnson & Johnson Research (2019 collaboration)U.S. Air Force (investor/collaborator)

Beyond the preview

Go deeper on Embr Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Embr Labs.

Explore the full profile